Skip to main content
S 649 112th Congress Senate Health Government information and archives Health information and medical records Health programs administration and funding Immunology and vaccination Medical research Musculoskeletal and skin diseases Research administration and funding

Scleroderma Research and Awareness Act

Introduced: March 17, 2011 Introduced by: Gillibrand, Kirsten E. Democratic · New York See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 17, 2011
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 17, 2011
Introduced in Senate
 Plain-English summary Congressional Research Service

Scleroderma Research and Awareness Act - Requires the Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases to expand, intensify, and coordinate the Institute's activities with respect to scleroderma, with particular emphasis on: (1) research focused on the etiology of scleroderma and the development of new treatment options, (2) clinical research to evaluate new treatment options, (3) basic research on the relationship between scleroderma and secondary conditions, (4) establishment of scleroderma patient registries, and (5) support for training of new clinicians and investigators with expertise in scleroderma.

Directs the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to carry out an educational campaign to increase public awareness of scleroderma.

What's happening now March 17, 2011

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Committees of jurisdiction 1
 Cosponsors 2
All 2 Democratic 2